RecruitingNCT07046585
Evaluation of the Natera Colorectal Cancer Screening Test in an Average Risk Population (FIND-CRC)
Sponsor
Natera, Inc.
Enrollment
25,000 participants
Start Date
May 30, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
The FIND-CRC study is a prospective collection of samples and data from participants who are at average risk of developing colorectal cancer (CRC). Collected samples and data will be analyzed to evaluate the clinical performance of the Natera CRC Screening Test.
Eligibility
Min Age: 40 Years
Plain Language Summary
Simplified for easier understanding
This study is testing a new blood-based colorectal cancer screening test (looking for cancer DNA in the blood) in average-risk people who are already planning to get a routine colonoscopy. The goal is to see how well this blood test compares to colonoscopy findings for detecting polyps or cancer.
**You may be eligible if...**
- You are 40 years or older
- You are planning to get a routine colonoscopy (not for symptoms — just routine screening)
- You have not had a colonoscopy in the past 9 years
- You are willing to give blood samples before your colonoscopy
**You may NOT be eligible if...**
- You have a personal history of any cancer (except for fully treated skin basal cell or squamous cell cancers)
- You have had precancerous polyps on a previous colonoscopy
- You are experiencing symptoms that prompted the colonoscopy
- You have inflammatory bowel disease or a hereditary cancer syndrome (like Lynch Syndrome)
- You have had prior colorectal surgery (other than for diverticular disease)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07046585
Related Trials
Clinicopathological Characteristics of Colon Cancer in Young Age
NCT053654121 location
A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors
NCT070850917 locations
Shield Post-Approval Study Protocol
NCT0688005556 locations
A Study of Biological, Genetic, and Constitutional Factors and Non-invasive Monitoring to Assess Personal Cancer Risks
NCT074697091 location
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
NCT071452557 locations